Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Metrics In Balance NV's enterprise value is €1.03 Mil.
Metrics In Balance NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was €0.03 Mil. Therefore, Metrics In Balance NV's EV-to-EBITDA for today is 41.00.
The historical rank and industry rank for Metrics In Balance NV's EV-to-EBITDA or its related term are showing as below:
XPAR:MLMIB'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -440.33 Med: 10.76 Max: 403.83
Current: 41
During the past 8 years, the highest EV-to-EBITDA of Metrics In Balance NV was 403.83. The lowest was -440.33. And the median was 10.76.
XPAR:MLMIB's EV-to-EBITDA is not ranked
in the Medical Distribution industry.
Industry Median: 8.59
vs XPAR:MLMIB: 41.00
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Metrics In Balance NV (XPAR:MLMIB) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Metrics In Balance NV's PE Ratio (TTM) for today is calculated as:
Metrics In Balance NV's share price for today is €0.033.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Metrics In Balance NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €0.002.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Metrics In Balance NV EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Metrics In Balance NV's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:MLMIB vs MCK, COR, CAH: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, Metrics In Balance NV's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Metrics In Balance NV EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Metrics In Balance NV's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Metrics In Balance NV's EV-to-EBITDA falls into.
Metrics In Balance NV's current Enterprise Value is €1.03 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Metrics In Balance NV's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was €0.03 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Metrics In Balance NV (XPAR:MLMIB) has a EV-to-EBITDA of 41.00 as of Sep. 01, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Metrics In Balance NV. This is 281% above median its historical median of 10.76.
Is Metrics In Balance NV's EV-to-EBITDA too high?
Metrics In Balance NV's current EV-to-EBITDA of 41.00 is 281% above median its 10-year median of 10.76. The Medical Distribution industry median EV-to-EBITDA is 8.59. Metrics In Balance NV's value of 41.00 is 377.3% above this industry median. Overall, Metrics In Balance NV has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Metrics In Balance NV's EV-to-EBITDA compare to MCK and COR?
Metrics In Balance NV's EV-to-EBITDA of 41.00 can be compared against companies in the Medical Distribution industry. The industry median EV-to-EBITDA is 8.59. Metrics In Balance NV's value of 41.00 is 377.3% above this benchmark. While the company's 10-year median is 10.76 vs. the industry median of 8.59, Metrics In Balance NV has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.59, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metrics In Balance NV's current EV-to-EBITDA of 41.00 is 377.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Metrics In Balance NV. For the Medical Distribution industry, the median EV-to-EBITDA is 8.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metrics In Balance NV's current EV-to-EBITDA is 41.00, which is 281% above median its own 10-year median of 10.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metrics In Balance NV stock overvalued right now?
Metrics In Balance NV (XPAR:MLMIB) has a current EV-to-EBITDA of 41.00. The current EV-to-EBITDA is 41.00, which is 281% above median its 10-year median of 10.76 and 377.3% above the Medical Distribution industry median of 8.59. Metrics In Balance NV's overall GF Score™ is 4/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Metrics In Balance NV (XPAR:MLMIB), the current EV-to-EBITDA is 41.00 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Metrics In Balance NV is engaged in the sale of medical devices for the measurement, diagnosis, and resolution of disorders related to dental occlusion malfunction.
4GF Score
Get the complete analysis for XPAR:MLMIB
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:MLMIB has been successfully added to your 
